| Literature DB >> 16681826 |
Abstract
Active immunization against existing cancer is a field that is currently in development and is associated with a number of problems. The potential use of peptides as minimal essential T-cell antigens and of mRNA as a novel form of antigen with advantages is discussed, with special consideration of practical aspects.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16681826 DOI： 10.1111/j.1440-1711.2006.01442.x
Source DB: PubMed Journal: Immunol Cell Biol ISSN： 0818-9641 Impact factor: 5.126